A detailed history of Bessemer Group Inc transactions in Insmed Inc stock. As of the latest transaction made, Bessemer Group Inc holds 300 shares of INSM stock, worth $22,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 160 87.5%
Holding current value
$22,017
Previous $11,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $8,680 - $11,061
140 Added 87.5%
300 $22,000
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $3,520 - $11,153
160 New
160 $11,000
Q2 2022

Aug 10, 2022

SELL
$17.07 - $25.71 $4,233 - $6,376
-248 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$32.28 - $44.3 $8,005 - $10,986
248 New
248 $8,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.94B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.